MedPath

Philippines FDA Approvals

FDA Philippines approved pharmaceutical products and drug approvals

Food and Drug Administration of the Philippines
Philippines
30,876 Approvals
Showing 30721 to 30740 of 30,876 approvalsPage 1537 of 1544

Chlorgen

Issued: Aug 1, 2023

Vancosan

Issued: Aug 1, 2023

Primegout

Issued: Aug 1, 2023

Unbranded

Issued: Aug 1, 2023

Flubit

Issued: Aug 1, 2023

Rapcenate

Issued: Aug 1, 2023

Ceftriasenz

Issued: Aug 1, 2023

Melotab

Issued: Aug 1, 2023

Indirin

Issued: Aug 1, 2023

Sapheron

Issued: Aug 1, 2023

Nasatapp

Issued: Aug 1, 2023

Difenax (reformulated)

Issued: Aug 1, 2023

Lourxime

Issued: Aug 1, 2023

Kaltrol

Issued: Aug 1, 2023

Unbranded

Issued: Aug 1, 2023

Maxigen

Issued: Aug 1, 2023

Rocy Gen

Issued: Aug 1, 2023
Panpharma GmbH

Glucost R

Issued: Aug 1, 2023

Olanzapro

Issued: Aug 1, 2023

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.